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Abstract: The assessment and control of microbial contamination in health care facilities is presently
a mandatory and vital part of strategies to prevent and control hospital-acquired infections. This
study aims to assess the bioburden with two passive sampling methods (30 ventilations grids swabs
and 16 electrostatic dust collectors (EDCs)) at Clinical Pathology Services. The fungal burden was
characterized through molecular tools, antifungal resistance, and the mycotoxins and cytotoxicity
profile. Total bacteria presented the highest prevalence in both matrixes, whereas Gram-bacteria
presented the lowest. Swabs presented a higher prevalence (27.6%) for fungal burden. Chrysonilia
sitophila presented the highest prevalence in swabs, whereas for EDCs, C. sitophila and Mucor sp.
were the most prevalent. Concerning Aspergillus genera on swabs, section Flavi was the one with the
highest prevalence (58.02%), whereas, for EDCs, section Versicolores was the only section observed
(100%). Aspergillus section Fumigati was detected in 10 swabs and 7 EDC samples and Aspergillus
section Versicolores was detected in one EDC sample. Fungal growth on azole-supplemented media
was observed in eight EDC samples. No mycotoxins were detected in any of the samples. A low
cytotoxic effect was observed in two sites upon incubation of collected samples with A549 and SK
cells and in two other sites upon incubation of collected samples with SK cells only. A medium
cytotoxic effect was observed with one EDC sample upon incubation with A549 cells. This study
reinforces the need of determination of the azole resistance profile for fungal species and allowed a
preliminary risk characterization regarding the cytotoxicity. An intervention including the use of a
ultraviolet with wavelength between 200 nm and 280 nm (UVC)—emitting device and an increased
maintenance and cleaning of the central heating, ventilation, and air conditioning (HVAC) systems
should be ensured to promote the reduction of microbial contamination.
Keywords: bioburden; passive methods; Aspergillus; azole resistance profile; cytotoxicity analysis
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1. Introduction
Hospital facilities are indoor environments with a high risk of cross infection between their
patients and staff. Studies performed in European hospitals [1] reported that nosocomial infections
add significantly to morbidity and mortality rates and that many of these infections are transmitted by
airborne pathogens [2]. Several everyday activities from health care facilities can boost bio-aerosols
dispersion [3–6], leading to infectious disease transmission. As such, the assessment and control of
microbial contamination in health care facilities is currently a mandatory and vital part of the strategies
to prevent and control hospital-acquired infections [7,8]. Aiming at addressing this challenging
assessment, several studies have already reported the upmost importance of applying passive sampling
methods [9–13]. These methods allow characterization of the contamination from a larger period of
time (weeks to several months) [14].
The presence of distinct species of airborne microorganisms in clinical environments may concur
for a wide range of negative health effects, both in patients, a potentially more vulnerable population,
and in clinical staff, long-term exposed to resident bioburdens during work tasks. The toxicity
and pathogenicity for humans of microorganisms varies greatly among genus and among species
within the same genus. The emergence worldwide of drug-resistant human pathogenic microbial
species, such as Methicillin-resistant Staphylococcus aureus (MRSA) and fungal species, such as
Candida sp. and Aspergillus fumigatus, and the increasing reports of therapeutic failure against fungal
infections [15–17] has revealed the need of surveillance of both bacterial and fungal resistance in health
care organizations [18,19].
Although it is not currently well known to which degree the exposure to toxigenic airborne
microbiota may contribute to actual adverse effects on human health, it is accepted, for instance, that
fungi development in buildings is unhealthy and must be prevented [20]. Bacteria and fungi can
promote allergic and infectious responses, and also inflammatory responses via inhalation of endotoxin
or ß-glucans [21,22]. Additionally, it has been suggested by previous studies that modification
of immune responses may be induced by long-term exposure to toxigenic fungi, leading to the
development of neurological symptoms, fever, cough, and fatigue [23].
Regarding fungi, Aspergillus fumigatus is one of the most studied species in clinical environments
due to their high prevalence as contaminants in clinical material, while being responsible for invasive
fungal infections among immunocompromised patients [24]. Their great toxicity is due to the
production of specific mycotoxins, such as aflatoxin B1, ochratoxin A, and gliotoxin. Indeed, in a
review by Viegas et al. from 2018 [25], it was possible to conclude the relevance to monitor mycotoxins
presence in clinical environments.
There are several published guidelines regarding ventilation of health care facilities [26–29].
However, the majority focuses on specialist facilities, such as isolation rooms, operating theatres, and
bronchoscopy wards, where the risk of infection is well characterized. In contrast, guidelines regarding
the ventilation of general wards, patient rooms, intensive care wards, or even other specific areas are
much scarcer and often dedicated to clinical cases and not to the indoor environment. The same gap
was found in microbial contamination studies, as indicated in scientific databases [13,14]. Furthermore,
almost all studies focused on patients’ health, disregarding clinical and laboratory health of staff [14].
However, the staff can transport and disseminate microbial contamination through all hospital facilities,
thus affecting patients [13].
Several studies were performed aiming at testing and recommending new technologies to ensure
air cleaning [30–33]. However, efforts should prioritize the exposure assessment to better characterize
and control the risk. This will allow the selection of the best and more suitable technologies.
To the best of our knowledge, no former studies were performed in a Clinical Pathology Service
of a central hospital, applying passive methods, such as a sampling approach. This study aims to
assess the bioburden using two passive sampling methods (ventilations grids and electrostatic dust
collectors). The fungal burden was also characterized through molecular tools for the toxigenic species,
antifungal resistance, and the mycotoxins and cytotoxicity profile.
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2. Materials and Methods
2.1. Indoor Environment Assessed and Sampling Locations
The present study was performed in June, 2019 in a Clinical Pathology Service from one central
hospital with 802 total number of hospital beds, comprising all hospital services. The hospital was
located in the Lisbon district. It was part of an enlarged exploratory study with financial support
to establish protocols for assessing occupational exposure to bioburdens in clinical environments.
The Clinical Pathology Service assessed included laboratory facilities, in which diagnosis of disease
was performed based on body fluids (biological samples). In this area, only hospital staff were allowed
in, with the exception of the collection rooms.
A walkthrough survey and checklist were used in order to prioritize the more critical
workplaces/areas regarding bioburdens, as previously published [13]. The assessed areas were
equipped with central heating, ventilation, and air conditioning (HVAC) systems, with air handing
units and a ductwork system. Filtered outdoor air was supplied through diffusers, coupled with grids
(ventilation grids) in the ceiling/above the door, and evacuated by corner outlets at the floor level.
Regarding the cleaning procedures, floors and surfaces were cleaned daily after laboratory service and
working hours and were performed by an external company.
The sampling procedures were focused in specific areas, namely, one collection room in the
emergency area, the core laboratory, the microbiology laboratory, six collection rooms, the triage
area, the mycobacteria lab, one office, the hematology lab, the immunology room, the worker’s
bedroom, bathroom, and canteen, and the immunoserology laboratory. In each area. two different
types of samples were collected: swab samples in the ventilation grid and electrostatic dust collector
(EDC) samples (Table 1). All the samples were collected in the same period of time, during a normal
working day.
Table 1. Samples collected in each location of the Clinical Pathology Service.
Location Number of Ventilation Grid Swab Samples Number of EDC Samples
Collection room—emergency area 2 1
Core lab 7 4
Microbiology lab 6 2
Collection room No. 8 1
Collection room No. 4 1
Collection room No. 3 1
Collection room No. 5 1
Collection room No. 6 1
Collection room No. 7 1
Triage area 1 1
Mycobacteria lab 2 1
Office 1 1
Hematology lab 2 1
Immunology room 2 1
Workers’ bedroom 1
Canteen 1
Immunoserology lab—PCR room 1 1
Workers’ bathroom 1
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2.2. Sampling and Characterization of the Viable Bioburden
Passive sampling methods were applied to determine the contamination levels of a greater period
of time and also to avoid any kind of disruption of the clinical activities. Ventilation grids (with 3 dm2
of area) samples (a total of 30) were collected by swabbing the grids. Swabs were subject to microbial
extraction following a specific protocol for extraction [13] and plated onto the selected media, namely
malt extract agar (MEA) supplemented with chloramphenicol (0.05%) and dichloran glycerol agar
(DG-18) were used for fungi; tryptic soy agar (TSA) supplemented with cycloheximide (0.1%) was
used to assess the bacterial load, and violet red bile agar (VRBA) to assess Gram negative bacteria.
Each EDC (a total of 16) had a surface expose area of 0.00942 m2 and dust was allowed to settle
down for 15 days before analysis. Settled dust collected by the EDC was weighted after sampling to
allow mass determination of the collected dust. EDC samples were subject to extraction and bioburden,
characterized by culture-based methods, as previously performed [14]. EDC extracts were seeded onto
the same culture media applied for the swabs.
EDC samples were screened for antifungal resistance on Sabouraud dextrose agar (SDA) media,
supplemented with 4 mg/L itraconazole (ITRA), 1 mg/L voriconazole (VORI), or 0.5 mg/L posaconazole
(POSA), with non-supplemented SDA as the control as performed previously [13,14].
2.3. Molecular Detection of Aspergillus Sections
Molecular identification of the different fungal species/strains was obtained by real-time PCR
(qPCR), using the automation system (CFX)-Connect PCR System (Bio-Rad). Reactions were performed,
using positive controls of DNA amplification, as indicated previously [13]. Reactions included 1× iQ
Supermix (Bio-Rad), 0.5 µM of each primer (Table 2), and 0.375 µM of TaqMan probe in a total volume
of 20 µL. For each gene amplified, a non-template control and a positive control, consisting of DNA
obtained from a reference, belonged to the culture collection of the Reference Unit for Parasitic and
Fungal Infections, Department of Infectious Diseases of National Institute of Health Dr. Ricardo Jorge.
These strains have been sequenced for Internal transcribed spacer (ITS), B-tubulin, and Calmodulin.
Table 2. Sequence of primers and TaqMan probes used for real-time PCR.
Fungal Species/Sections Targeted Sequences Reference
Flavi (Toxigenic Strains)
Forward Primer 5‘–GTCCAAGCAACAGGCCAAGT–3‘
Reverse Primer 5‘–TCGTGCATGTTGGTGATGGT–3‘ [34]
Probe 5‘–TGTCTTGATCGGCGCCCG–3‘
Fumigati
Forward Primer 5‘–CGCGTCCGGTCCTCG–3‘
Reverse Primer 5‘–TTAGAAAAATAAAGTTGGGTGTCGG–3‘ [35]
Probe 5‘–TGTCACCTGCTCTGTAGGCCCG–3‘
Circumdati
Forward Primer 5‘–CGGGTCTAATGCAGCTCCAA–3‘
Reverse Primer 5‘–CGGGCACCAATCCTTTCA–3‘ [12]
Probe 5‘–CGTCAATAAGCGCTTTT–3‘
Versicolores
Forward Primer
Reverse Primer 5’–CGGCGGGGAGCCCT–3’
5’–CCATTGTTGAAAGTTTTGACTGATCTTA–3’
Probe 5’–AGACTGCATCACTCTCAGGCATGAAGTTCAG–3’ [36]
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2.4. Mycotoxins Analysis
EDC samples (0.05 g) were extracted by shaking 2.5 mL of mixture of acetonitrile (ACN) with:
water (H2O): acetic acid (AcOH) (79:20:1) for 90 min. After centrifugation (5 min, 5000 rpm), each
sample (2 mL) was evaporated under nitrogen and reconstituted in a mobile phase (0.2 mL; A:B 7:3).
Mycotoxins detection was developed through the use of a high-performance liquid chromatograph
(HPLC) Nexera (Shimadzu, Tokyo, Japan), with a mass detector 5500 QTrap (Sciex, Foster City, CA,
USA) (Table 3). Mycotoxins were separated on a chromatographic column Gemini C18 (150 × 4.6 mm,
5 µm) (Phenomenex, Torrance, CA, USA). The flow rate was 1 mL/min and the injection volume was
5 µL. Mobile phases were: a methanol/water/acetic acid 10/89/1 (v/v/v) and B methanol/water/acetic
acid 97/2/1 (v/v/v) (both phases contained 5 mmol/L ammonium acetate) with the following gradient:
0% B up to 2 min, 50% B from 2 to 5 min, 100% B from 5 to 14 min, 100% B up to 18 min, then 0% B
to 22.5 min. The Tandem Mass Spectrometry MS/MS was performed in scheduled multiple reaction
monitoring (sMRM) mode in both in negative and positive polarities in one chromatographic run
per sample. The Characterization of Electrospray Ionization (ESI)-source parameters were as follows:
curtain gas 30 psi, collision gas medium, ionspray voltage 4500 V (negative polarity) and 5500 V
(positive polarity), temperature 550 ◦C, ion source gas1 80 psi, ion source gas2 80 psi.
Table 3. Detection and quantification values for each mycotoxin (ng/g).
Mycotoxins Limit of Detection (LOD) Limit of Quantification (LOQ)
15-Acetyldeoxynivalenol 2.8 9.4
3-Acetyldeoxynivalenol 5.1 1.9
Aflatoxin B1 0.3 0.9
Aflatoxin B2 0.2 0.8
Aflatoxin G1 0.6 2.1
Aflatoxin G2 0.7 2.2
Aflatoxin M1 0.3 0.9
α-Zearalanol 1.0 3.3
α-Zearalenol 1.3 4.5
β-Zearalanol 1.1 3.8
β-Zearalenol 1.7 5.6
Deepoxydeoxynivalenol 6.2 20.7
Deoxynivalenol 3.5 11.7
Diacetoxyscirpenol 1.6 5.4
DON-3-Glucosid 3.2 10.6
Fumonisin B1 12.2 40.8
Fumonisin B2 7.5 25.0
Fumonisin B3 8.4 27.9
Fusarenon-X 7.7 25.6
Gliotoxin 4.2 13.9
Griseofulvin 0.8 2.7
HT-2 Toxin 1.6 5.2
Mevinolin 1.1 3.7
Moniliformin 2.7 8.9
Monoacetoxyscirpenol 3.4 11.4
Mycophenolic acid 2.5 8.2
Neosolaniol 3.1 10.3
Nivalenol 4.3 14.5
Ochratoxin A 0.5 1.6
Ochratoxin B 1.7 5.7
Patulin 8.3 27.6
Roquefortine C 4.1 13.6
Sterigmatocystin 0.7 2.2
T-2 Tetraol 8.0 26.7
T-2 Toxin 0.7 2.4
T-2 Triol 2.5 8.4
Zearalanone 1.3 4.3
Zearalenon 0.9 3.0
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2.5. Cell Culture and MTT Assay
Cell viability of was determined after incubation of a swine kidney monolayer (SK) and
adenocarcinomic human alveolar basal epithelial (A549) cell lines with EDC samples. Cells were
maintained in tissue culture flasks (TPP) medium (minimum essential medium (MEM) with Earle’s
salts, Sigma-Aldrich, St. Louis, MO, USA), supplemented with antibiotics (Penicillin, Streptomycin
(Sigma-Aldrich, St. Louis, MO, USA)) and fetal bovine serum (Sigma-Aldrich, St. Louis, MO, USA)
at 37 ◦C in a humidified atmosphere with 5% CO2. For the assay, cells were harvested with trypsin/
Ethylenediaminetetraacetic acid solution (EDTA) (1:10, v:v) in phosphate buffered saline (PBS) and
plated in flat bottom 96-microtiter plates (TPP) in 100 µL culture medium at densities of about
2.5 × 105 cells/mL.
Colorimetric assay for assessing cell metabolic activity (MTT) assay was used to assess
cellular viability after incubation with EDC samples through cleavage of MTT tetrazolium salt
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide). The formation of formazan crystals
was measured by spectrophotometrical absorbance of the samples using the ELISA microplate reader
(ELISA LEDETECT 96, biomed Dr. Wieser GmbH) at a wavelength of 510 nm.Data analysis was
performed with MikroWin 2013SC software (Labsis, Neunkirchen-Seelscheid, Germany). The threshold
toxicity level was defined as the lowest concentration of the extract that causes a drop in sample
absorption to values <50% of cell division activity, as evaluated by the dilution method.
2.6. Statistical Analysis
The data were analyzed in statistical software, SPSS 22.0 for Windows. The results were considered
significant at the 5% significance level. The Shapiro–Wilk test was used to test the normality of the
data. Frequency analysis (n; %), and the calculation of the minimum and maximum medians were
performed for the qualitative and quantitative data, respectively. The Spearman correlation coefficient
was used to study the relationship between fungal and bacterial contamination and cytotoxicity.
3. Results
3.1. Bioburden Characterization
Total bacteria (TSA) presented the highest prevalence in both matrixes (99.99% Swabs; 100% EDC),
whereas Gram-Bacteria (VRBA) presented the lowest (0.01% Swabs; 0% EDC) (Table 4).
Table 4. Bioburden distribution on swabs and EDC.
Bacterial Contamination
Swabs
Mean (SD) CFU
TSA 2.3 × 102 (2.4 × 102)
VRBA 3.3 × 10−2 (17.9 × 10−2)
EDC
Mean (SD) CFU m−2
TSA 7.2 × 102 (9.6 × 102)
VRBA 0.0 × 102 (0.0 × 102)
Fungal contamination
Swabs
Mean (SD) CFU
MEA 2.4 × 102 (3.2 × 102)
DG18 0.6 × 102 (1.4 × 102)
EDC
Mean (SD) CFU m−2
MEA 0.7 × 102 (0.06 × 102)
DG18 1.7 × 102 (0.05 × 102)
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Concerning the fungal burden, the highest prevalence for swabs was observed on MEA (27.6%),
whereas EDC presented the highest prevalence on DG18 (91.9%) (Table 4).
Concerning the number of different fungal species in each matrix, swabs presented 16 different
species in both media, whereas EDC presented nine different species in MEA media and seven in
DG18 media.
Chrysonilia sitophila presented the highest prevalence in swabs in both media (52.50% MEA; 60.93%
DG18), followed by Penicillium sp. in MEA (18.43%) and Cladosporium sp. in DG18 (25.02%) (Figure 1).
In EDC, Cladosporium sp. presented the highest prevalence in DG18 media (45.98%), whereas, on MEA,
the highest prevalence belonged to C. sitophila and Mucor sp. (44.52%) (Figure 1).
Atmosphere 2020, 11, x FOR PEER REVIEW 7 of 17 
 
 
Swabs 
   Mean (SD) CFU 
MEA 2.4 × 102 (3.2 × 102) 
DG18 0.6 × 102 (1.4 × 102) 
EDC 
  Mean (SD) CFU m−2 
MEA 0.7 × 102 (0.06 × 102) 
DG18 1.7 × 102 (0.05 × 102) 
Concerning the number of different fungal species in each matrix, swabs presented 16 different 
species in both media, whereas EDC presented nine different species in MEA media and seven in 
DG18 media. 
Chrysonilia sitophila presented the highest prevalence in swabs in both media (52.50% MEA; 
60.93% DG18), followed by Penicillium sp. in MEA (18.43%) and Cladosporium sp. in DG18 (25.02%) 
(Figure 1). In EDC, Cladosporium sp. presented the highest prevalence in DG18 media (45.98%), 
whereas, on MEA, the highest prevalence belonged to C. sitophila and Mucor sp. (44.52%) (Figure 1). 
 
Figure 1. Fungal distribution on both environmental matrices. 
Among Aspergillus genera, section Flavi was the one with the highest prevalence on MEA 
(58.02%) and Nigri section on DG18 (55.41%). Referring to the EDC samples, section Versicolores was 
the section that presented the highest prevalence in both media (100% MEA; 75% DG18). However, 
the Aspergillus section Circumdati (25%) was also found in DG18 (Table 5). 
Table 5. Aspergillus section distribution on swabs and EDC. 
Swabs 
MEA DG18 
Sections CFU % Sections CFU % 
Flavi  47 58.02 Nigri  41 55.41 
Nigri  28 34.57 Circumdati  14 18.92 
Versicolores  3 3.70 Flavi  14 18.92 
Circumdati  3 3.70 Aspergilli  3 4.05 
    Versicolores 2 2.70 
Total 81 100.00 Total 74 100.00 
EDC 
0
23.56
8.73
45.98
52.50
57.39
44.52
11.49
0 0
44.52
0
18.43
12.72
0
26.44
17.24
6.33
2.23
16.09
11.83
0 0 0.00
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
60.00%
70.00%
MEA DG18 MEA DG18
Swabs EDC's
Cladosporium sp.
C. sitophila
Mucor spp.
Penicillium sp.
Other Species
Alternaria sp.
Figure 1. Fungal distribution on both environ ental atrices.
Aspergillus genera, section Flavi was the on with the ig st prevalenc on MEA (58.02%)
and Nigri section on DG18 (55.41%). Referring to the EDC samples, section Ver icol res was the section
at prese ted he highest prevalence in both media (100% MEA; 75% DG18). However, the Aspergillus
section Circumdati (25%) was also found in DG18 (Table 5).
. ill i i i i .
MEA DG18
Sections CFU % Sections CFU %
Flavi 47 58.02 Nigri 41 55.41
Nigri 28 34.57 Circumdati 14 18.92
Versicolores 3 3.70 Flavi 14 18.92
Circumdati 3 3.70 Aspergilli 3 4.05
Versicolores 2 2.70
Total 81 100.00 Total 74 100.00
EDC
MEA DG18
Sections CFU m−2 % Sections CFU m−2 %
Versicolores 212.31 100.00 Versicolores 636.94 75.00
Circumdati 212.31 25.00
Total 212.31 100.00 Total 849.26 100.00
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Fungal growth on azole-supplemented media was observed in eight EDC samples on ITRA, 10
samples on VORI, and three samples on POSA. The most frequent species were: C. sitophila on SAB
(97.51%), Cladosporium sp. on ITRA (27.27%) and VORI (68.00%), and Penicillium sp. on POSA (66.67%)
(Table 6). Cladosporium sp. was able to grow in more than one azole in two EDC samples, namely from
“Core lab” (ITRA+VORI) and from “Microbiology” (ITRA+VORI+POSA).
Table 6. Fungal azole resistance distribution.
EDC
SAB ITRA VORI POSA
Species CFU m−2 % CFU m−2 % CFU m−2 % CFU m−2 %
Acremonium sp. 106.16 4.55
Alternaria sp. 106.16 4.55
Aureobasidium sp. 212.31 0.08
C. sitophila 266,029.72 97.51 530.79 22.73 530.79 20.00
Chrysonilia sp. 212.31 0.08
Chrysosporium sp. 318.47 0.12 530.79 22.73
Aspergillus section
Circumdati 212.31 0.08
Cladosporium sp. 4140.13 1.52 636.94 27.27 1804.67 68.00 106.1571 33.33
Fusarium
verticilloides 318.47 0.12
Penicillium sp. 1380.04 0.51 424.63 18.18 318.47 12.00 212.31 66.67
TOTAL 272,823.78 100.00 2335.46 100.00 2653.93 100.00 318.47 100.00
Among the four Aspergillus sections investigated by qPCR in swab samples from ventilation grids
and in the EDC, only two were detected. Aspergillus section Fumigati was detected in 10 swab samples
(10 out of 15; 66.67%) and 7 EDC samples (7 out of 12; 58.33%) (Table 7). Interestingly, Fumigati was not
detected by culture-based methods in any of the samples (EDC and ventilation grid swabs).
Table 7. Molecular detection results from the EDC and ventilation grids swab samples.
Aspergillus
Section Detected Sample Type Location
CFU/CFU m−2
(MEA/DG18)
Cq
Aspergillus section
Fumigati
Ventilation grids
swabs
Core lab 0/0 36.08
Collection room No. 8 0/0 39.36
Collection room No. 5 0/0 35.94
Collection room No. 6 0/0 35.23
Collection room No. 7 0/0 39.25
Triage area 0/0 36.57
Mycobacteria lab 0/0 37.85
Hematology lab 0/0 36.23
Immunology lab 0/0 35.56
Immunoserology lab—PCR room 0/0 35.85
EDC
Collection room—emergency area 0/0 35.93
Microbiology lab 0/0 37.82
Hematology lab 0/0 37.77
Immunology lab 0/0 38.66
Workers’ bedroom 0/0 35.34
Canteen 0/0 36.82
Immunoserology lab—PCR room 0/0 39.71
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Table 7. Cont.
Aspergillus
Section Detected Sample Type Location
CFU/CFU m−2
(MEA/DG18)
Cq
Aspergillus section
Versicolores
Ventilation grids
swabs
Collection room—emergency area 0.5/0 -
Core lab 0/0.14 -
Microbiology lab 0.17/0.17 -
Hematology lab 0.5/0 -
EDC
Core lab 26.54/0 -
Workers’ bedroom 0/0 32.79
Canteen 106.16/530.79 -
Workers’ bathroom 0/106.16 -
The Aspergillus section Versicolores was detected in one EDC sample by qPCR (1 out of 12; 8.33%)
(Table 7); although it was detected in more samples by culture-based methods (3 out of 12 EDC samples;
25%, and 4 out of 15 swab samples; 26.67%), none of which corresponded to the sample detected at the
molecular level (the workers’ bedroom EDC sample).
3.2. Cytotoxicity Analysis
EDC samples were submitted to a cytotoxicity evaluation in two distinct cell lines A549 and SK cells
via application of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) colorimetric
assay. The MTT assay assesses cell viability by means of reducing the yellow tetrazolium salt to
insoluble formazan. A semi-quantitative scale for cytotoxicity grading was adopted: low cytotoxic
effect (+) for percentage of extinction values ranging from 80% to 90%, medium cytotoxic effect (++)
for values ranging from 60% to 79%, and a high effect (+++) for values below 60%. The absence
of cytotoxicity was determined when the extinction values were at ≥90. A low cytotoxic effect was
observed in two locals with A549 and SK cells (“Collection room-emergency area” and “Core lab”) and
in other two locals with SK cells only (“Immunoserology lab-PCR room” and “Worker’s bathroom”).
The medium cytotoxic effect was observed with one EDC sample from “Canteen” on A549 cells.
Although isolated analysis of two EDC samples from “Core lab” also revealed a medium cytotoxic
effect on SK or A549 cells, in average, and “Core lab” presented a low cytotoxicity effect in vitro
(Figure 2). Atmosphere 2020, 11, x FOR PEER REVIEW 10 of 17 
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Regarding mycotoxins analysis, in all the samples analyzed, there were no mycotoxins detected.
3.3. Comparison and Correlation Analysis
Comparing the various collection sites from the swabs, it was found that the room-emergency
area and office sites were the ones with the highest fungi counts on MEA (CFU) and on DG18 (CFU),
whereas triage areas, offices, hematology labs, immunology rooms, and immunoserology lab-PCR
rooms were the ones with the highest total bacteria counts (TSA (CFU)). Concerning Gram-bacteria
(VRBA (CFU)), none of the sites revealed their presence (Figure 3). In EDC, all sites had identical counts
of both fungi and bacteria, except for the office, which had higher counts of fungi on MEA (Figure 4).
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The following correlations were detected on swabs: (i) total bacteria (TSA) counts on swabs (CFU)
and TSA counts on EDC (CFU m−2) (rs = −0.719, p = 0.006), which meant that higher TSA counts (CFU)
on swabs were related to lower TSA counts (CFU m−2) on EDC; (ii) TSA counts on swabs (CFU) and
A549 cells (rs = 0.610, p = 0.027), revealing that higher TSA counts (CFU) on swabs were related to
higher A549 cell viability, thus, lower cytotoxicity; (iii) Fungi counts on MEA (CFU) on swabs and
fungi counts on DG18 (CFU) on swabs (rs = 0.628, p < 0.0001), revealing that higher MEA counts on
swabs (CFU) were related to higher DG18 counts (CFU) on swabs; (iv) MEA counts (CFU) on swabs
and MEA counts (CFU m−2) on EDC (rs = 0.742, p = 0.004) and with DG18 counts (CFU m−2) on EDC
(rs = 0.645, p = 0.017), indicating that higher MEA counts (CFU) on swabs were related with higher
MEA counts (CFU m−2) on EDC and higher DG18 counts (CFU m−2) on EDCs (Table 8).
Table 8. Study of the relationship between microbial contamination and cell viability (MTT assay)
(Spearman correlation coefficient results).
Swabs EDC Cell Viability
MEA
(CFU)
DG18
(CFU)
TSA
(CFU m−2)
MEA
(CFU m−2)
DG18
(CFU m−2)
SK Cells (%
Extinction)
A549 Cells (%
Extinction)
Swabs
TSA (CFU) −0.022 0.231 −0.719 ** −0.196 −0.006 0.158 0.610 *
MEA (CFU) 0.628 ** 0.502 0.742 ** 0.645 * −0.071 −0.484
DG18 (CFU) −0.003 0.350 0.383 0.196 −0.047
EDC
TSA
(CFU m−2) 0.509 * 0.490 * −0.172 −0.729**
MEA
(CFU m−2) 0.861 ** 0.033 −0.462
DG18
(CFU m−2) 0.232 −0.344
Cell
viability SK cells 0.127
** Correlation is significant at the 0.01 level (2-tailed). * Correlation is significant at the 0.05 level (2-tailed).
The following correlations were detected on EDC: (i) TSA counts on EDC (CFU m−2), MEA counts
(CFU m−2), and DG18 counts (CFU m−2), both in EDC (rs = 0.509, p = 0.037 and rs = 0.490, p = 0.046,
respectively), which means that higher TSA counts (CFU m−2) on EDC were related to higher MEA
counts (CFU m−2) and higher DG18 counts (CFU m−2) on EDC; (ii) TSA counts (CFU m−2) on EDC and
A549 cells (rs = −0.729, p = 0.001), revealing that higher TSA counts (CFU m−2) on EDC were related
to lower A549 cell viability, thus, higher cytotoxicity; (iii) MEA counts (CFU m−2) and DG18 counts
(CFU m−2) on EDC (rs = 0.861, p < 0.0001), indicating that higher MEA counts (CFU m−2) on EDC
were related to higher DG18 counts (CFU m−2) on EDC (Table 8).
4. Discussion
The sampling approach applied on this study allows us to recognize the advantages of using
more than one sampling method [13]. Indeed, different counts and biodiversity (swabs: 16 different
species in both media, EDC: 9 different species in MEA, and 7 in DG18) were observed in each
environmental sample, allowing us to obtain a more accurate bioburden characterization. Additionally,
using different agar media allowed bacteriota discrimination between total bacteria and Gram-bacteria.
Regarding fungi, this approach has allowed the detection of a wider diversity concerning the Aspergillus
genera, as well as the identification of different resistant profiles within the identified fungi. As such,
the combination of these factors has promoted differentiation of the fungal species detected. Thus, it
will be possible to introduce targeted cleaning procedures in specific surfaces, such as walls and floors,
consistent with the fact that hospital surfaces might be a source for dissemination of microorganisms
transported to the hands of patients or staff [37]. Indeed, hospital environments could be a source
of outbreaks of resistant organisms [38], and experts suggest indirect transmission through the
environment, besides direct person-to-person transmission [39].
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The efficacy of biocides in eliminating microbial contaminants within healthcare facilities has
been studied in the last years [40–44]. The widespread and increasing use of products containing
low concentrations of biocidal agents or presenting low activity raises the concern of microorganisms’
selection through development of acquired resistance and selection of less susceptible microorganisms
following exposure to biocidals. Although this phenomenon is mainly described for bacteria, the same
principle applies to fungal development of resistance to antifungal agents used in the environment
and cross-resistance to antifungal drugs. The rational of using biocidals in healthcare facilities should,
therefore, be supported by the evidence on their added value and targeted to specific applications,
for which the risks have been established. For that reason, the characterization of a microbial resistance
profile in the healthcare facilities’ environment is of upmost importance.
Therefore, more than one sampling approach and more than one culture media should be the
trend to be applied by exposure assessors (industrial hygienists or Indoor Air Quality assessors) when
analyzing/sampling health care facilities [13].
Molecular tools were very efficient in detecting Aspergillus section Fumigati, whereas, for section
Versicolores, the culture-based methods were more valuable. These differences highlight the importance
of using culture-based methods for assessing the viable component of bioburden [13], combined
with real-time PCR assay for targeting the indicators of harmful fungal contamination [45]. Indeed,
culture-based methods can reveal less abundant fungi in a specific occupational environment when
compared with more refined molecular tools (e.g., high-throughput sequencing) that provide a more
exhaustive diversity profile [46]. However, although in less counts, the presence of some Aspergillus
sections (opportunistic pathogens) may represent a health risk for patients and workers who are exposed
on a daily basis [46]. Of note is the increased detection of Aspergillus section Fumigati, responsible by
80% of the cases of invasive aspergillosis, the most common invasive fungal infection [47].
Concerning the fact that mycotoxins null results, this can be due to several aspects, including
the fact that the fungi are not stimulated to produce mycotoxins due to environmental reasons.
However, since toxigenic species were found in the samples collected, this situation can change if
some environmental variable changes. Therefore, the fact that no mycotoxins were measured does not
allow discarding the need of future campaigns that will also monitor mycotoxins. Indeed, previous
reports have already detected mycotoxins in health care centers, particularly in air and HVAC filter
samples [13], justifying this need.
No Aspergillus sections were observed in azole screening media. Nevertheless, the Circumdati
section was observed in Sabouraud. The burden of Aspergillus species in azole supplemented media
might be underestimated due to presence of fast-growing species, such as C. sitophila on ITRA and
VORI, and requires further investigation. In fact, molecular tools revealed the presence of other
Aspergillus sections (Fumigati and Versicolores) in EDC not detected by culture. The fact that two samples
(from Core lab and Microbiology) showed the same fungal species (Cladosporium and Penicillium)
in two different azole media might suggest the development of multi-resistance to azoles, although
this requires confirmation by minimum inhibitory concentration (MIC) determination by a reference
method, such as The European Committee on Antimicrobial Susceptibility Testing (EUCAST). Previous
studies from our group performed in health care centers also revealed (in settled dust samples) the
co-occurrence in the same sample of Penicillium growth in ITRA and VORI [48]. Another study on
indoor air quality also describes fungal growth in the three azoles for Penicillium and Cladosporium [13]
and raises the question of the need of determination of the azole resistance profile for fungal species
that might represent some health risk.
EDC sampling allowed a preliminary risk characterization regarding the cytotoxicity in human
alveolar basal epithelial cells as a model for in vitro inhalation toxicology [49,50] and in swine kidney
monolayer cells as a model for renal in vitro toxicology [51] through incubation of cell lines with
airborne substances present in the sampled places. According to the defined threshold levels for
cytotoxicity, airborne substances with a potential medium cytotoxic effect were recovered from three
EDC samples from locals with some of the highest bacterial (TSA counts) and/or fungal (MEA)
Atmosphere 2020, 11, 351 13 of 16
contamination levels: “canteen” and “core lab”. However, no cytotoxic effect was observed in the
“office”, where the highest microbial contamination was found. Statistical analysis revealed no relation
between fungal contamination and cytotoxicity and contradictory results, regarding the role of bacterial
contamination on cytotoxicity, depending on the sampling method. While bacterial contamination
(TSA) on EDC seems to negatively affect A549 cell viability, the contrary was observed with swab
sampling. These results suggest that other factors besides microbial contamination may be associated
with in vitro cytotoxicity, namely, the presence of specific toxigenic species and/or particulate matter
and/or other irritant agents in the collected samples. It is noteworthy that toxigenic Aspergillus species
were detected in EDC samples collected in canteen (Aspergillus sections Fumigati and Versicolores) and
in core lab (Aspergillus section Versicolores). However, such a statement may not provide grounds for a
definite conclusion about the compared species of fungi that display a more cytotoxic effect than others.
The comparison between sampling sites regarding microbial contamination allowed us to prioritize
intervention regarding which biocidals (for fungi/bacteria elimination) should be applied in each
sampling site. However, it was found among the bioburden analyzed that a positive correlation between
both sampling methods was applied. Thus, an intervention aiming at air cleaning with ultraviolet
germicidal irradiation, such as ultraviolet with wavelength between 200 nm and 280 nm (UVC) [30]
should be ensured, covering both fungi and bacteria elimination in the Clinical Pathology Service.
Additionally, HVAC systems (including ventilation grids) should be maintained and properly preserved,
since their efficacy in reducing microbial contamination has already been demonstrated [52,53].
5. Conclusions
Overall, it was possible to conclude that the two sampling methods used in this study—swabs
and EDCs—unveiled a more complete characterization of the bioburden, permitting us to obtain
information regarding workers and patient’s potential exposure. Additionally, culture-based methods
and molecular tools used in parallel should be used in order to perform an accurate characterization of
the fungal contamination. This study also reinforces the need of analyzing the azole resistance profile
for fungal species that might represent some health risk. EDC sampling allowed a preliminary risk
characterization regarding the cytotoxicity present in the sampled places. Still, further studies are
needed for a definite conclusion about the fungal species that display more cytotoxic effects when
compared to others.
An intervention including the use of a UVC-emitting device in the Clinical Pathology Service
and an increased maintenance and cleaning of the HVAC systems should be ensured to promote the
reduction of microbial contamination.
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